|
Market Closed -
Hong Kong S.E.
04:08:29 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 8.700 HKD | -1.86% |
|
-10.12% | +3.20% |
| 09-15 | CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Lung Cancer Drug | MT |
| 09-15 | CSPC Pharmaceutical says SYS6010 granted breakthrough therapy designation by NMPA | RE |
ETFs positioned on CSPC Pharmaceutical Group Limited
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
| +11.06% | -.--% | 27,154 M€ | ||
| +9.15% | -.--% | 274 M€ | ||
| +19.46% | -.--% | 4,070 M€ | ||
| -2.76% | -.--% | 21 M€ | ||
| +10.12% | -.--% | 67 M€ | ||
| +9.25% | -.--% | 122 M€ | ||
| +21.74% | -.--% | 182 M€ | ||
| -2.57% | -.--% | 283 M€ | ||
| +0.29% | 4.14% | 5 M€ | ||
| +10.66% | 3.2% | 169 M€ | ||
| -9.07% | 2.29% | 65 M€ | ||
| +6.95% | 1.68% | 124 M€ | ||
| -23.14% | 1.51% | 5 M€ | ||
| +7.84% | 1.32% | 249 M€ | ||
| +27.00% | 1.16% | 886 M€ | ||
| +5.44% | 1.02% | 272 M€ | ||
| -.--% | 0.86% | 111 M€ | ||
| -11.03% | 0.86% | 511 M€ | ||
| -13.12% | 0.75% | 251 M€ | ||
| +16.97% | 0.63% | 89 M€ | ||
| +18.54% | 0.59% | 153 M€ | ||
| -12.41% | 0.58% | 85 M€ | ||
| -10.99% | 0.57% | 50 M€ | ||
| +14.79% | 0.54% | 27 M€ | ||
| -7.25% | 0.47% | 244 M€ | ||
| +17.12% | 0.47% | 174 M€ | ||
| +16.87% | 0.47% | 2,223 M€ | ||
| +34.14% | 0.45% | 47 M€ | ||
| +29.03% | 0.45% | 172 M€ | ||
| -14.06% | 0.43% | 89 M€ | ||
| +10.91% | 0.43% | 792 M€ | ||
| -11.92% | 0.4% | 6,244 M€ | ||
| +21.59% | 0.39% | 156 M€ | ||
| +14.98% | 0.37% | 3,246 M€ |
Employees
18,626
Sector
Pharmaceuticals
Calendar
- Stock Market
- Stocks
- 1093 Stock
- ETFs CSPC Pharmaceutical Group Limited
Select your edition
All financial news and data tailored to specific country editions
















